MedTrace Logo

Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis

NCT04662268 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2020-12-10

No results posted yet for this study

Summary

Our objective is to determine a prognostic score including CT, clinical and biological criteria predicting the serious (death / surgery) or non-serious (medical treatment) evolution of ischemic colitis and therefore possibly modify the therapeutic management (propose surgical treatment for a severe form based on prognostic score).

Conditions

  • Ischemic Colitis

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Patrice TAOUREL, MD-PhD · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2020-11-01
Completion
2020-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04662268 on ClinicalTrials.gov